|
39
|
1 <html>
|
|
|
2
|
|
|
3 <head>
|
|
|
4 <meta http-equiv=Content-Type content="text/html; charset=windows-1252">
|
|
|
5 <meta name=Generator content="Microsoft Word 14 (filtered)">
|
|
|
6 <style>
|
|
|
7 <!--
|
|
|
8 /* Font Definitions */
|
|
|
9 @font-face
|
|
|
10 {font-family:Calibri;
|
|
|
11 panose-1:2 15 5 2 2 2 4 3 2 4;}
|
|
|
12 /* Style Definitions */
|
|
|
13 p.MsoNormal, li.MsoNormal, div.MsoNormal
|
|
|
14 {margin-top:0in;
|
|
|
15 margin-right:0in;
|
|
|
16 margin-bottom:10.0pt;
|
|
|
17 margin-left:0in;
|
|
|
18 line-height:115%;
|
|
|
19 font-size:11.0pt;
|
|
|
20 font-family:"Calibri","sans-serif";}
|
|
|
21 .MsoChpDefault
|
|
|
22 {font-family:"Calibri","sans-serif";}
|
|
|
23 .MsoPapDefault
|
|
|
24 {margin-bottom:10.0pt;
|
|
|
25 line-height:115%;}
|
|
|
26 @page WordSection1
|
|
|
27 {size:8.5in 11.0in;
|
|
|
28 margin:1.0in 1.0in 1.0in 1.0in;}
|
|
|
29 div.WordSection1
|
|
|
30 {page:WordSection1;}
|
|
|
31 -->
|
|
|
32 </style>
|
|
|
33
|
|
|
34 </head>
|
|
|
35
|
|
|
36 <body lang=EN-US>
|
|
|
37
|
|
|
38 <div class=WordSection1>
|
|
|
39
|
|
|
40 <p class=MsoNormalCxSpFirst style='text-align:justify'><b><span lang=EN-GB
|
|
|
41 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Info
|
|
|
42 table</span></b></p>
|
|
|
43
|
|
|
44 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
|
45 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>This
|
|
|
46 table contains information on different characteristics of SHM. For all
|
|
|
47 characteristics information can be found for all sequences or only sequences of
|
|
|
48 a certain (sub)class. All results are based on the sequences that passed the filter
|
|
|
49 settings chosen on the start page of the SHM & CSR pipeline and only
|
|
|
50 include details on the analysed region as determined by the setting of the
|
|
|
51 sequence starts at filter. All data in this table can be downloaded via the
|
|
|
52 “downloads” tab.</span></p>
|
|
|
53
|
|
|
54 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
|
55 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Mutation
|
|
|
56 frequency:</span></u></p>
|
|
|
57
|
|
|
58 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK83"></a><a
|
|
|
59 name="OLE_LINK82"></a><a name="OLE_LINK81"><span lang=EN-GB style='font-size:
|
|
|
60 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These values
|
|
|
61 give information on the level of SHM. </span></a><a name="OLE_LINK22"></a><a
|
|
|
62 name="OLE_LINK21"></a><a name="OLE_LINK20"><span lang=EN-GB style='font-size:
|
|
|
63 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>More information
|
|
|
64 on the values found in healthy individuals of different ages can be found in </span></a><a
|
|
|
65 name="OLE_LINK15"></a><a name="OLE_LINK14"></a><a name="OLE_LINK13"><span
|
|
|
66 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IJspeert
|
|
|
67 and van Schouwenburg et al, PMID: 27799928</span></a></p>
|
|
|
68
|
|
|
69 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
70 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Number
|
|
|
71 of mutations:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:
|
|
|
72 115%;font-family:"Times New Roman","serif"'> Shows the number of total
|
|
|
73 mutations / the number of sequenced bases (the % of mutated bases).</span></p>
|
|
|
74
|
|
|
75 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
76 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Median
|
|
|
77 number of mutations:</span></i><span lang=EN-GB style='font-size:12.0pt;
|
|
|
78 line-height:115%;font-family:"Times New Roman","serif"'> Shows the median % of
|
|
|
79 SHM of all sequences.</span></p>
|
|
|
80
|
|
|
81 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
|
82 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Patterns
|
|
|
83 of SHM:</span></u></p>
|
|
|
84
|
|
|
85 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK72"></a><a
|
|
|
86 name="OLE_LINK71"></a><a name="OLE_LINK70"><span lang=EN-GB style='font-size:
|
|
|
87 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These values
|
|
|
88 give insights into the targeting and patterns of SHM. These values can give
|
|
|
89 insight into the repair pathways used to repair the U:G mismatches introduced
|
|
|
90 by AID. </span></a><a name="OLE_LINK40"></a><a name="OLE_LINK39"></a><a
|
|
|
91 name="OLE_LINK38"></a><a name="OLE_LINK60"><span lang=EN-GB style='font-size:
|
|
|
92 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>More information
|
|
|
93 on the values found in healthy individuals of different ages can be found in
|
|
|
94 IJspeert and van Schouwenburg et al, PMID: 27799928</span></a></p>
|
|
|
95
|
|
|
96 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
97 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transitions:</span></i><span
|
|
|
98 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
99 Shows the number of transition mutations / the number of total mutations (the
|
|
|
100 percentage of mutations that are transitions). Transition mutations are C>T,
|
|
|
101 T>C, A>G, G>A. </span></p>
|
|
|
102
|
|
|
103 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
104 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transversions:</span></i><span
|
|
|
105 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
106 Shows the number of transversion mutations / the number of total mutations (the
|
|
|
107 percentage of mutations that are transitions). Transversion mutations are
|
|
|
108 C>A, C>G, T>A, T>G, A>T, A>C, G>T, G>C.</span></p>
|
|
|
109
|
|
|
110 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
111 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transitions
|
|
|
112 at GC:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
113 font-family:"Times New Roman","serif"'> <a name="OLE_LINK2"></a><a
|
|
|
114 name="OLE_LINK1">Shows the number of transitions at GC locations (C>T,
|
|
|
115 G>A) / the total number of mutations at GC locations (the percentage of
|
|
|
116 mutations at GC locations that are transitions).</a></span></p>
|
|
|
117
|
|
|
118 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
119 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Targeting
|
|
|
120 of GC:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
121 font-family:"Times New Roman","serif"'> <a name="OLE_LINK7"></a><a
|
|
|
122 name="OLE_LINK6"></a><a name="OLE_LINK3">Shows the number of mutations at GC
|
|
|
123 locations / the total number of mutations (the percentage of total mutations
|
|
|
124 that are at GC locations).</a> </span></p>
|
|
|
125
|
|
|
126 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
127 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transitions
|
|
|
128 at AT:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
129 font-family:"Times New Roman","serif"'> Shows the number of transitions at AT
|
|
|
130 locations (T>C, A>G) / the total number of mutations at AT locations (the
|
|
|
131 percentage of mutations at AT locations that are transitions).</span></p>
|
|
|
132
|
|
|
133 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
134 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Targeting
|
|
|
135 of AT:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
136 font-family:"Times New Roman","serif"'> Shows the number of mutations at AT
|
|
|
137 locations / the total number of mutations (the percentage of total mutations
|
|
|
138 that are at AT locations).</span></p>
|
|
|
139
|
|
|
140 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
141 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>RGYW:</span></i><span
|
|
|
142 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
143 <a name="OLE_LINK28"></a><a name="OLE_LINK27"></a><a name="OLE_LINK26">Shows
|
|
|
144 the number of mutations that are in a RGYW motive / The number of total mutations
|
|
|
145 (the percentage of mutations that are in a RGYW motive). </a><a
|
|
|
146 name="OLE_LINK62"></a><a name="OLE_LINK61">RGYW motives are known to be
|
|
|
147 preferentially targeted by AID </a></span><span lang=EN-GB style='font-size:
|
|
|
148 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(R=Purine,
|
|
|
149 Y=pyrimidine, W = A or T).</span></p>
|
|
|
150
|
|
|
151 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
152 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>WRCY:</span></i><span
|
|
|
153 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
154 <a name="OLE_LINK34"></a><a name="OLE_LINK33">Shows the number of mutations
|
|
|
155 that are in a </a><a name="OLE_LINK32"></a><a name="OLE_LINK31"></a><a
|
|
|
156 name="OLE_LINK30"></a><a name="OLE_LINK29">WRCY</a> motive / The number of
|
|
|
157 total mutations (the percentage of mutations that are in a WRCY motive). WRCY
|
|
|
158 motives are known to be preferentially targeted by AID </span><span lang=EN-GB
|
|
|
159 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(R=Purine,
|
|
|
160 Y=pyrimidine, W = A or T).</span></p>
|
|
|
161
|
|
|
162 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
163 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>WA:</span></i><span
|
|
|
164 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
165 <a name="OLE_LINK37"></a><a name="OLE_LINK36"></a><a name="OLE_LINK35">Shows
|
|
|
166 the number of mutations that are in a WA motive / The number of total mutations
|
|
|
167 (the percentage of mutations that are in a WA motive). It is described that
|
|
|
168 polymerase eta preferentially makes errors at WA motives </a></span><span
|
|
|
169 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(W
|
|
|
170 = A or T).</span></p>
|
|
|
171
|
|
|
172 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
173 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>TW:</span></i><span
|
|
|
174 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
175 Shows the number of mutations that are in a TW motive / The number of total mutations
|
|
|
176 (the percentage of mutations that are in a TW motive). It is described that
|
|
|
177 polymerase eta preferentially makes errors at TW motives </span><span
|
|
|
178 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(W
|
|
|
179 = A or T).</span></p>
|
|
|
180
|
|
|
181 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
|
182 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Antigen
|
|
|
183 selection:</span></u></p>
|
|
|
184
|
|
|
185 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
|
186 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These
|
|
|
187 values give insight into antigen selection. It has been described that during
|
|
|
188 antigen selection, there is selection against replacement mutations in the FR
|
|
|
189 regions as these can cause instability of the B-cell receptor. In contrast
|
|
|
190 replacement mutations in the CDR regions are important for changing the
|
|
|
191 affinity of the B-cell receptor and therefore there is selection for this type
|
|
|
192 of mutations. Silent mutations do not alter the amino acid sequence and
|
|
|
193 therefore do not play a role in selection. More information on the values found
|
|
|
194 in healthy individuals of different ages can be found in IJspeert and van
|
|
|
195 Schouwenburg et al, PMID: 27799928</span></p>
|
|
|
196
|
|
|
197 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
198 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>FR
|
|
|
199 R/S:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
200 font-family:"Times New Roman","serif"'> <a name="OLE_LINK43"></a><a
|
|
|
201 name="OLE_LINK42"></a><a name="OLE_LINK41">Shows the number of replacement
|
|
|
202 mutations in the FR regions / The number of silent mutations in the FR regions
|
|
|
203 (the number of replacement mutations in the FR regions divided by the number of
|
|
|
204 silent mutations in the FR regions)</a></span></p>
|
|
|
205
|
|
|
206 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
207 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>CDR
|
|
|
208 R/S:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
209 font-family:"Times New Roman","serif"'> Shows the number of replacement
|
|
|
210 mutations in the CDR regions / The number of silent mutations in the CDR
|
|
|
211 regions (the number of replacement mutations in the CDR regions divided by the
|
|
|
212 number of silent mutations in the CDR regions)</span></p>
|
|
|
213
|
|
|
214 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
|
215 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Number
|
|
|
216 of sequences nucleotides:</span></u></p>
|
|
|
217
|
|
|
218 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
|
219 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These
|
|
|
220 values give information on the number of sequenced nucleotides.</span></p>
|
|
|
221
|
|
|
222 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
223 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Nt
|
|
|
224 in FR:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
225 font-family:"Times New Roman","serif"'> <a name="OLE_LINK46"></a><a
|
|
|
226 name="OLE_LINK45"></a><a name="OLE_LINK44">Shows the number of sequences bases
|
|
|
227 that are located in the FR regions / The total number of sequenced bases (the
|
|
|
228 percentage of sequenced bases that are present in the FR regions).</a></span></p>
|
|
|
229
|
|
|
230 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
231 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Nt
|
|
|
232 in CDR:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
233 font-family:"Times New Roman","serif"'> Shows the number of sequenced bases
|
|
|
234 that are located in the CDR regions / <a name="OLE_LINK48"></a><a
|
|
|
235 name="OLE_LINK47">The total number of sequenced bases (the percentage of
|
|
|
236 sequenced bases that are present in the CDR regions).</a></span></p>
|
|
|
237
|
|
|
238 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
239 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>A:
|
|
|
240 </span></i><a name="OLE_LINK51"></a><a name="OLE_LINK50"></a><a
|
|
|
241 name="OLE_LINK49"><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
242 font-family:"Times New Roman","serif"'>Shows the total number of sequenced
|
|
|
243 adenines / The total number of sequenced bases (the percentage of sequenced
|
|
|
244 bases that were adenines).</span></a></p>
|
|
|
245
|
|
|
246 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
247 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>C:
|
|
|
248 </span></i><a name="OLE_LINK53"></a><a name="OLE_LINK52"><span lang=EN-GB
|
|
|
249 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows
|
|
|
250 the total number of sequenced cytosines / The total number of sequenced bases
|
|
|
251 (the percentage of sequenced bases that were cytosines).</span></a></p>
|
|
|
252
|
|
|
253 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
254 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>T:
|
|
|
255 </span></i><a name="OLE_LINK57"></a><a name="OLE_LINK56"><span lang=EN-GB
|
|
|
256 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows
|
|
|
257 the total number of sequenced </span></a><a name="OLE_LINK55"></a><a
|
|
|
258 name="OLE_LINK54"><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
259 font-family:"Times New Roman","serif"'>thymines</span></a><span lang=EN-GB
|
|
|
260 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>
|
|
|
261 / The total number of sequenced bases (the percentage of sequenced bases that
|
|
|
262 were thymines).</span></p>
|
|
|
263
|
|
|
264 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB
|
|
|
265 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>G:
|
|
|
266 </span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%;
|
|
|
267 font-family:"Times New Roman","serif"'>Shows the total number of sequenced <a
|
|
|
268 name="OLE_LINK59"></a><a name="OLE_LINK58">guanine</a>s / The total number of
|
|
|
269 sequenced bases (the percentage of sequenced bases that were guanines).</span></p>
|
|
|
270
|
|
|
271 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK69"><b><span
|
|
|
272 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Graphs</span></b></a></p>
|
|
|
273
|
|
|
274 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK75"></a><a
|
|
|
275 name="OLE_LINK74"></a><a name="OLE_LINK73"><span lang=EN-GB style='font-size:
|
|
|
276 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These graphs visualize
|
|
|
277 information on the patterns and targeting of SHM and thereby give information
|
|
|
278 into the repair pathways used to repair the U:G mismatches introduced by AID. The
|
|
|
279 data represented in these graphs can be downloaded in the download tab. More
|
|
|
280 information on the values found in healthy individuals of different ages can be
|
|
|
281 found in IJspeert and van Schouwenburg et al, PMID: 27799928</span></a><span
|
|
|
282 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>.
|
|
|
283 <a name="OLE_LINK85"></a><a name="OLE_LINK84"></a></span></p>
|
|
|
284
|
|
|
285 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
|
286 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Percentage
|
|
|
287 of mutations in AID and pol eta motives</span></u></p>
|
|
|
288
|
|
|
289 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
|
290 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Visualizes
|
|
|
291 <a name="OLE_LINK80"></a><a name="OLE_LINK79"></a><a name="OLE_LINK78">for each
|
|
|
292 (sub)class </a>the percentage of mutations that are present in AID (RGYW or
|
|
|
293 WRCY) or polymerase eta motives (WA or TW) in the different subclasses </span><span
|
|
|
294 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(R=Purine,
|
|
|
295 Y=pyrimidine, W = A or T).</span></p>
|
|
|
296
|
|
|
297 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=NL
|
|
|
298 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Relative
|
|
|
299 mutation patterns</span></u></p>
|
|
|
300
|
|
|
301 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
|
302 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Visualizes
|
|
|
303 for each (sub)class the distribution of mutations between mutations at AT
|
|
|
304 locations and transitions or transversions at GC locations. </span></p>
|
|
|
305
|
|
|
306 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=NL
|
|
|
307 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Absolute
|
|
|
308 mutation patterns</span></u></p>
|
|
|
309
|
|
|
310 <p class=MsoNormalCxSpLast style='text-align:justify'><span lang=EN-GB
|
|
|
311 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Visualized
|
|
|
312 for each (sub)class the percentage of sequenced AT and GC bases that are
|
|
|
313 mutated. The mutations at GC bases are divided into transition and transversion
|
|
|
314 mutations<a name="OLE_LINK77"></a><a name="OLE_LINK76">. </a></span></p>
|
|
|
315
|
|
|
316 <p class=MsoNormal><span lang=NL style='font-size:12.0pt;line-height:115%;
|
|
|
317 font-family:"Times New Roman","serif"'>Hanna IJspeert, Pauline A. van
|
|
|
318 Schouwenburg, David van Zessen, Ingrid Pico-Knijnenburg, Gertjan J. Driessen,
|
|
|
319 Andrew P. Stubbs, and Mirjam van der Burg (2016). </span><span
|
|
|
320 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Evaluation
|
|
|
321 of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and
|
|
|
322 Adults. In <i>Frontiers in Immunolog, 7, pp. e410-410. </i>[<a
|
|
|
323 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span
|
|
|
324 style='color:windowtext'>doi:10.3389/fimmu.2016.00410</span></a>][<a
|
|
|
325 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span
|
|
|
326 style='color:windowtext'>Link</span></a>]</span></p>
|
|
|
327
|
|
|
328 </div>
|
|
|
329
|
|
|
330 </body>
|
|
|
331
|
|
|
332 </html>
|
